focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - SHIRE PLC

24 Dec 2018 11:38

RNS Number : 4521L
Morgan Stanley Capital Services LLC
24 December 2018
 

 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

21 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 ADR

 PURCHASES

 97,979

 171.8900 USD

 169.7100 USD

 

 ADR

 SALES

 2,464

 171.5500 USD

 169.5900 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 ADR

 CFD

 LONG

 167

 171.5440 USD

 

 ADR

 CFD

 SHORT

 100

 169.7100 USD

 

 ADR

 CFD

 SHORT

 100

 169.7100 USD

 

 ADR

 CFD

 SHORT

 200

 169.9900 USD

 

 ADR

 CFD

 SHORT

 66,700

 170.0300 USD

 

 ADR

 CFD

 SHORT

 200

 170.0300 USD

 

 ADR

 CFD

 SHORT

 30,000

 170.0300 USD

 

 ADR

 CFD

 SHORT

 30,175

 170.0300 USD

 

 ADR

 CFD

 SHORT

 66,725

 170.0300 USD

 

 ADR

 CFD

 SHORT

 400

 170.2912 USD

 

 ADR

 CFD

 SHORT

 200

 170.5925 USD

 

 ADR

 CFD

 SHORT

 167

 171.1000 USD

 

 5p ordinary

 CFD

 LONG

 39,824

 44.8106 GBP

 

 5p ordinary

 CFD

 LONG

 39

 44.8950 GBP

 

 5p ordinary

 CFD

 LONG

 850

 44.9544 GBP

 

 5p ordinary

 CFD

 SHORT

 4,200

 44.8950 GBP

 

 5p ordinary

 CFD

 SHORT

 16,950

 44.8950 GBP

 

 5p ordinary

 CFD

 SHORT

 279,200

 44.8950 GBP

 

 5p ordinary

 CFD

 SHORT

 79,890

 44.8950 GBP

 

 5p ordinary

 CFD

 SHORT

 27,490

 44.8950 GBP

 

 5p ordinary

 CFD

 SHORT

 1,040

 44.9674 GBP

 

 5p ordinary

 CFD

 SHORT

 21,610

 44.9674 GBP

 

 5p ordinary

 CFD

 SHORT

 6,950

 44.9674 GBP

 

 5p ordinary

 CFD

 SHORT

 4,260

 44.9674 GBP

 

 5p ordinary

 CFD

 SHORT

 8,430

 45.0616 GBP

 

 5p ordinary

 CFD

 SHORT

 37,600

 45.0616 GBP

 

 5p ordinary

 CFD

 SHORT

 13,740

 45.0616 GBP

 

 5p ordinary

 CFD

 SHORT

 2,290

 45.0616 GBP

 

 5p ordinary

 CFD

 SHORT

 40,000

 45.0984 GBP

 

 5p ordinary

 CFD

 SHORT

 10,000

 45.0984 GBP

 

 5p ordinary

 CFD

 SHORT

 6,530

 45.1560 GBP

 

 5p ordinary

 CFD

 SHORT

 29,789

 45.1560 GBP

 

 5p ordinary

 CFD

 SHORT

 28,601

 45.1560 GBP

 

 5p ordinary

 CFD

 SHORT

 4,746

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 3,466

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 163

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 3,371

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 1,069

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 650

 45.3176 GBP

 

 5p ordinary

 CFD

 SHORT

 7,660

 45.3409 GBP

 

 5p ordinary

 CFD

 SHORT

 12,601

 45.3409 GBP

 

 5p ordinary

 CFD

 SHORT

 39,729

 45.3409 GBP

 

 5p ordinary

 CFD

 SHORT

 1,917

 45.3409 GBP

 

 5p ordinary

 CFD

 SHORT

 1,670

 56.9206 USD

 

 5p ordinary

 CFD

 SHORT

 1,670

 56.9206 USD

 

 5p ordinary

 CFD

 SHORT

 85,980

 56.9512 USD

 

 5p ordinary

 CFD

 SHORT

 5,043

 56.9513 USD

 

 5p ordinary

 CFD

 SHORT

 3,649

 56.9513 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 24 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFMMZZMDKGRZM
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.